19. February 2019 | 16:44
Six years of conflict in Central African Republic has offered little respite to citizens. An MSF report outlines the extreme violence our teams have witnessed and the ineffectiveness of MINUSCA, the UN’s peacekeeping mission in CAR.
14. February 2019 | 18:22
Snakebite overwhelmingly affects the rural poor, such as migrant harvest workers in northern Ethiopia. Access to treatment remains difficult, due to high prices for antivenoms, and the unavailability of effective antivenom in remote places.
14. February 2019 | 17:29
MSF staff have treated hundreds of people with urgent needs living in a makeshift camp in far northwestern Cameroon after 35,000 fled violence in Rann, northeastern Nigeria.
14. February 2019 | 14:29
A measles epidemic was declared in March 2018 in the former province of Katanga, southeastern Democratic Republic of Congo (DRC). Nearly 12 months on, MSF teams are still responding to the outbreak, vaccinating and treating children.
14. February 2019 | 10:15
MSF has opened a new emergency room in Ad Dahi hospital, Hodeidah governorate, Yemen, where 100-year old Omar was recently our first patient.
12. February 2019 | 16:17
Médecins Sans Frontières (MSF) has started enrolling patients in clinical trials of four potential new treatments for Ebola in treatment centres in Katwa and Butembo, North Kivu, Democratic Republic of Congo.
11. February 2019 | 17:01
Staff from the El Salvador Ministry of Health were able, thanks to MSF’s presence, to cross the invisible borders imposed by violence that hinders access to health in some neighborhoods in the capital.
11. February 2019 | 16:30
8. February 2019 | 13:33
In the provinces of North Kivu and South Kivu, Democratic Republic of Congo (DRC), people – particularly pregnant women – face challenges in accessing health care; insecurity and conflict in the region, long distances between villages and health centres, roads that become muddy rivers in the rainy season.
8. February 2019 | 6:57
MSF is supporting two survivors of drug-resistant tuberculosis challenging a patent on bedaquiline. If they are successful, generic versions of the drug could be available four years earlier, saving thousands of lives.